Brain Cancer Study: Magnitude Of Post-vaccine Immune Response Linked To Clinical Outcomes

Researchers conducting a clinical trial of a dendritic cell vaccine designed to fight malignant brain tumors called glioblastoma multiforme have found a correlation between the "intensity" of a patient's immune response and clinical outcome, according to an article in the journal Cancer Research.

Read the whole article on Science Daily

More from Science Daily